Safety of dual biological therapy in Crohn’s disease: a case series of vedolizumab in combination with other biologics

Uncertainty exists regarding safety and efficacy of dual biological therapy (DBT) in inflammatory bowel disease. We present four cases of DBT in Crohn’s disease. Three patients had refractory disease non-responsive to biological monotherapy or combination therapy with immunomodulators. One patient h...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Eric J, Lewin, Sara, Terdiman, Jonathan P, Beck, Kendall
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254738/
https://www.ncbi.nlm.nih.gov/pubmed/30538822
http://dx.doi.org/10.1136/bmjgast-2018-000243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254738/
https://www.ncbi.nlm.nih.gov/pubmed/30538822
http://dx.doi.org/10.1136/bmjgast-2018-000243

Ejemplares similares